Literature DB >> 29345206

Successful treatment of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation with bortezomib.

Ling Cao1, Liang Piu Koh2, Yeh Ching Linn1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29345206     DOI: 10.1080/10428194.2017.1421759

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  3 in total

1.  Autoimmune Cytopenias Post Hematopoietic Stem Cell Transplantation in Pediatric Patients With Osteopetrosis and Other Nonmalignant Diseases.

Authors:  Ehud Even-Or; Yael Dinur Schejter; Adeeb NaserEddin; Irina Zaidman; Bella Shadur; Polina Stepensky
Journal:  Front Immunol       Date:  2022-05-27       Impact factor: 8.786

Review 2.  Development of New Drugs for Autoimmune Hemolytic Anemia.

Authors:  Zhengrui Xiao; Irina Murakhovskaya
Journal:  Pharmaceutics       Date:  2022-05-11       Impact factor: 6.525

Review 3.  Autoimmune Hemolytic Anemia in Chronic Myeloid Leukemia.

Authors:  Tahseen Hamamyh; Mohamed A Yassin
Journal:  Pharmacology       Date:  2020-06-02       Impact factor: 2.547

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.